Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 43 min ago
PreprintCC BYbioRxiv

Live 4D monitoring of fungal infection in an ex vivo model of fungal keratitis reveals enhanced efficacy of combined PACK-CXL and natamycin treatment

  1. 1Manchester Metropolitan University

Abstract

Fungal keratitis (FK) is a major cause of visual impairment worldwide, yet the development and evaluation of new therapeutic approaches are limited by experimental models that inadequately reproduce deep stromal infection or permit longitudinal quantification of fungal burden. Here, we developed an ex vivo porcine corneal model of Aspergillus fumigatus keratitis that supports reproducible fungal invasion into the deeper corneal stroma and enables non-destructive monitoring of infection over time. Optimisation of the culture conditions demonstrated that reducing nutrient availability markedly promoted stromal penetration compared with nutrient rich conditions. Using a YFP expressing A. fumigatus strain combined with confocal microscopy and three-dimensional image analysis, fungal burden could be quantified repeatedly within individual corneas, allowing changes in established infection to be monitored longitudinally. We applied the model to evaluate natamycin and photoactivated chromophore for keratitis corneal cross-linking (PACK-CXL), alone and in combination. Both monotherapies significantly restricted the increase in fungal burden observed in untreated corneas, but neither consistently reduced pre-existing fungal burden. In contrast, combined natamycin and PACK-CXL treatment reduced fungal burden in all treated corneas and was significantly more effective than either treatment alone. Together, these findings establish a quantitative ex vivo platform for investigating invasive A. fumigatus corneal infection and demonstrate its ability to distinguish between treatments that restrict fungal expansion and those that reduce established fungal burden. The model provides a useful approach for the longitudinal evaluation and optimisation of therapeutic interventions for fungal keratitis.

Related

  1. Enhanced Neutralizing Antibody Responses to Rhinovirus C and Age-Dependent Patterns of Infection
    T. Choi, M. Devries, L. B. Bacharier +39
    American Journal of Respiratory and Critical Care MedicinePeer-reviewedLicence not stated44 citedMicrobiologyHAL
  2. An updated review of monkeypox virus infection's global prevalence and health risks with supporting treatment and diagnosis
    Krishna Kumar Bharti, Sunit Kumar Gupta, Bhaskarjyoti Saha +1
    VirusDiseasePeer-reviewedLicence not statedFull text1 citedMicrobiologyPMC
  3. Pseudomonas aeruginosa evolves to an infection state of reduced virulence and enhanced survival during antibiotic selection in an airway tissue model
    A. M. Smania, A. H. Tenaglia, C. A. M. Colque +7
    bioRxivPreprintCC BYFull textMicrobiologybioRxiv
  4. Myeloid cell reprogramming drives enhanced defense against Streptococcus pneumoniae lung infection following exposure to commensal Prevotella.
    Sara N Stoner, Eric D Larson, Sam Fulte +5
    Proceedings of the National Academy of Sciences of the United States of AmericaPeer-reviewedCC BYFull text1 citedImmunologyEurope PMC
  5. Ti₃C₂T x MXene-Enhanced Paper-Based Ion-Selective Electrodes for Sweat Sodium Monitoring.
    Wanda Cimmino, Md Abu Zahed, Michele Spinelli +4
    ACS measurement science auPeer-reviewedCC BY-NC-NDFull textSystems & synthetic biologyEurope PMC
BibTeX
@misc{sivanesan2026live,
  title = {{Live 4D monitoring of fungal infection in an ex vivo model of fungal keratitis reveals enhanced efficacy of combined PACK-CXL and natamycin treatment}},
  author = {O. Sivanesan and N. Van Rhijin and S. Y. Tang and M. J. Bromley and C. Zhao},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.02.748893},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.02.748893v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Live 4D monitoring of fungal infection in an ex vivo model of fungal keratitis reveals enhanced efficacy of combined PACK-CXL and natamycin treatment
AU  - O. Sivanesan
AU  - N. Van Rhijin
AU  - S. Y. Tang
AU  - M. J. Bromley
AU  - C. Zhao
PY  - 2026
DA  - 2026/09/02
PB  - bioRxiv
DO  - 10.64898/2026.09.02.748893
UR  - https://www.biorxiv.org/content/10.64898/2026.09.02.748893v1
AB  - Fungal keratitis (FK) is a major cause of visual impairment worldwide, yet the development and evaluation of new therapeutic approaches are limited by experimental models that inadequately reproduce deep stromal infection or permit longitudinal quantification of fungal burden. Here, we developed an ex vivo porcine corneal model of Aspergillus fumigatus keratitis that supports reproducible fungal invasion into the deeper corneal stroma and enables non-destructive monitoring of infection over time. Optimisation of the culture conditions demonstrated that reducing nutrient availability markedly promoted stromal penetration compared with nutrient rich conditions. Using a YFP expressing A. fumigatus strain combined with confocal microscopy and three-dimensional image analysis, fungal burden could be quantified repeatedly within individual corneas, allowing changes in established infection to be monitored longitudinally. We applied the model to evaluate natamycin and photoactivated chromophore for keratitis corneal cross-linking (PACK-CXL), alone and in combination. Both monotherapies significantly restricted the increase in fungal burden observed in untreated corneas, but neither consistently reduced pre-existing fungal burden. In contrast, combined natamycin and PACK-CXL treatment reduced fungal burden in all treated corneas and was significantly more effective than either treatment alone. Together, these findings establish a quantitative ex vivo platform for investigating invasive A. fumigatus corneal infection and demonstrate its ability to distinguish between treatments that restrict fungal expansion and those that reduce established fungal burden. The model provides a useful approach for the longitudinal evaluation and optimisation of therapeutic interventions for fungal keratitis.
ER  -